Kappa-type opioid receptor
G-protein coupled opioid receptor that functions as receptor for endogenous alpha-neoendorphins and dynorphins, but has low affinity for beta-endorphins. Also functions as receptor for various synthetic opioids and for the psychoactive diterpene salvinorin A. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain. Plays a role in mediating reduced physical activity upon treatment with synthetic opioids. Plays a role in the regulation of salivation in response to synthetic opioids. May play a role in arousal and regulation of autonomic and neuroendocrine functions.
| Database | Links |
|---|---|
| UniProt | P41145 |
| PDB | 2A0D, 2IQN, 4DJH |
| BioGrid | 111031 |
| BindingDB | P41145 |
| DrugBank | DB00921, DB00611, DB00907, DB00318, DB01209, DB00956, DB00327, DB00454, DB00370, DB00295, DB00844, DB00704, DB00497, DB00652, DB00647, DB00193 |
| Guide to PHARMACOLOGY | 318 |
| PharmGKB | PA31943 |
| KEGG | hsa:4986 |
| BioCyc | Not available |
| Entrez Gene (GeneID) | 4986 |
| Metric | Mean Value | Standard Deviation |
|---|---|---|
| AUC | 0.9528 | 0.0011 |
| Accuracy | 0.9067 | 0.002 |
| Sensitivity | 0.89 | 0.0021 |
| Specificity | 0.9227 | 0.0031 |
| BEDROC | 0.9812 | 0.0017 |
| MCC Threshold | 0.496 | N/A |
| MCC | 0.8119 | N/A |
| F-score Threshold | 0.468 | N/A |
| F-score | 0.9027 | N/A |